Technology supply

Products, technologies or know-how owned by Parc Taulí and clinically validated that need to be marketed in order to reach society, either through operating and / or distribution licenses, or technology transfer agreements.

tAby Diagnostics

We are looking for: licensees and investors

Taby Diagnostics is a project in the transfer phase, in which a technology has been developed that allows to increase the sensitivity of in vitro diagnostic test of different types of cancer. By structurally modifying tumor-associated antigens, Taby technology can detect autoantibodies in patient serum. So far this technology has been tested in patients with cirrhosis, in which the concentration of autoantibodies against alpha-fetoprotein (AFP) has been measured, in order to be able to diagnose early those who were going to develop cancer. of liver. The results demonstrate a sensitivity of the test of 100% and a specificity of 94%, thus doubling the sensitivity of the screening methods currently used in this type of patients.

Anais Medical

We are looking for: licensees, distributors, investors

Anais Medical is the result of more than 30 years of experience in training vascular access techniques. This project arose from the need to bring medical simulation closer to reality through models and simulators that allow training in invasive procedures. We use proprietary technology to provide more realistic models, in which all anatomical components and layers resemble humans. Anais Medical has developed three different simulation models to improve the skills of clinical experts in different fields, such as nephrology, surgery, radiology or nursing. Specifically, we have developed models to train the creation of arteriovenous fistulas, to reproduce endovascular interventions, and to train punctures.

Parametric Medicine

We are looking for: investors, CEO

Parametric Medicine designs patient-specific 3D printed surgical guides, which help reduce complexity during surgeries, improve surgeon skills, reduce surgery time and associated costs.
The main opportunity for healthcare providers to use bespoke surgical guides is to reduce their review rate. Surgical guides also reduce the duration of surgery and, in turn, save costs. By reducing the number of revision surgeries and the duration of surgeries, hospitals could be further adjusted at the same time and with the same amount of staff resources.

EPPICS

We are looking for: investors, CEO

EPPICS is an innovative digital tool based on our previous proof of concept, which will improve patient recovery and comfort during the stay in the ICU. EPPICS has several exercises for the prevention of functional alterations at the cognitive and emotional level, and is integrated into a communicator for those patients who do not have the ability to communicate.
Early intervention has been shown to be key to reducing patient sequelae after ICU discharge. In addition, it has been shown that interventions

LuCaDAlert

We are looking for: licensees

LuCaDAlert is a new diagnostic imaging software to detect lung cancer on unreported chest x-rays based on algorithms of deep learning. Although more advanced technologies exist, radiographs remain the most widely used system in examinations performed in radiology services. It is estimated that in Spain 75% of radiographs are not reported by a radiologist, and it is known that the same happens in other countries. Because the diagnosis of lung cancer on x-rays is complex, there are currently images with signs of cancer ignored within the healthcare system network. LuCaDAlert would be integrated into this healthcare system, allowing x-rays to be pre-screened for signs consistent with lung cancer, and alerting radiologists to confirm the suspicion of diagnosis. In this way, patients who have been examined for other reasons will be diagnosed quickly. Our system will clearly contribute to the improvement of the prognosis of the disease by favoring the detection.

On this website we use cookies, mainly from third parties. If you continue browsing, we understand that you agree.